Filing Flows › CervoMed (CRVO) › Q3 2025 › vs Q2 2025
CervoMed (CRVO) Q3 2025 vs Q2 2025 (quarter over quarter)
CervoMed's revenue fell $1.4M (-82%) from $1.8M in Q2 2025 to $323K in Q3 2025.
CervoMed, Q3 2025: revenue $323K (-83% year over year), net loss $7.7M, operating cash flow −$6.5M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q3 2025 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $323K | $1.8M | −$1.4M | -82% |
| Other income, net | $318K | $358K | −$40K | -11% |
| Net loss | $7.7M | $6.3M | $1.5M | +23% |
| Costs & expenses | $8.4M | $8.4M | −$7K | -0.1% |
| Operating costs | $8.4M | $8.4M | −$7K | -0.1% |
| Research & development | $6.0M | $5.1M | $932K | +18% |
| General & admin | $2.3M | $3.3M | −$939K | -29% |
| Operating cash sources | $7.7M | $6.3M | $1.5M | +23% |
| Share-based compensation | $292K | $497K | −$205K | -41% |
| Working capital & other | $970K | −$753K | $1.7M | — |
| Cash used in operations | $6.5M | $6.5M | −$49K | -0.8% |
| Net loss absorbed | $7.7M | $6.3M | $1.5M | +23% |
Questions
How much did CervoMed's revenue grow quarter over quarter in Q3 2025?
CervoMed's revenue fell $1.4M (-82%) from $1.8M in Q2 2025 to $323K in Q3 2025.